Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 24, 2024

Primary Completion Date

January 25, 2026

Study Completion Date

January 25, 2026

Conditions

Familial Hypercholesterolemia

Interventions

DRUG

YOLT-101

The IP is administered intravenously at the predetermined dose.

Trial Locations (1)

RECRUITING

Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER